Innovation Showcase Friday lunchtime
Human pluripotent stem cells (hPSCs) hold tremendous promise for a wide range of applications, including regenerative medicine, disease modeling, drug discovery and toxicology. Recently, there has been a dramatic increase in the generation of genome-edited hPSC lines due to widespread use of the CRISPR-Cas9 technology. As a result, researchers are becoming more aware of the critical importance of cell quality for generating robust and relevant data. This seminar will focus on how to maintain and assess high-quality hPSC cultures throughout the various stages of your research with an emphasis on five critical quality control aspects: genomic integrity, pluripotency, gene and marker expression, the epigenetic landscape and culture morphology. Speakers will also discuss the ArciTect™ family of products for ribonucleoprotein-based CRISPR-Cas9 genome editing, providing you with a rapid, flexible and precise protocol to modify the hPSC genome for various applications. Finally, methods to model neurological disease with cerebral organoids derived from high-quality hPSCs will be discussed.
Innovation Showcase: STEMCELL Technologies 2
11:30 - 12:30
Stemcell Technologies Inc, British Columbia, Canada
STEMCELL Technologies Inc., British Columbia, Canada
11:30 - 12:30
Innovation Showcase: HUMAN PLURIPOTENT STEM CELL QUALITY: ESSENTIAL CONSIDERATIONS FOR GENE EDITING, CLONING, MAINTENANCE AND DISEASE MODELING - STEMCELL Technologies